Skip to main content
. 2022 May 7;12:7506. doi: 10.1038/s41598-022-11491-3

Table 2.

Subgroups of LF-LG AS according to AVACT.

Characteristic High-gradient severe AS (n = 438) Classic LF-LG AS (n = 18) Paradoxical LF-LG AS (n = 55)
AVACT < 1.2 cm2 AVACT ≥ 1.2 cm2 P-value AVACT < 1.2 cm2 AVACT ≥ 1.2 cm2 P-value AVACT < 1.2 cm2 AVACT ≥ 1.2 cm2 P-value
No. of patients (%) 395 (90.2) 43 (9.8) 13 (72.2) 5 (27.8) 47 (85.5) 8 (14.5)
Age, years 66.8 ± 8.9 67.0 ± 8.4 0.92 66.1 ± 5.8 68.6 ± 7.7 0.46 67.3 ± 9.2 67.3 ± 10.9 0.99
Male 201 (50.9) 35 (81.4) < 0.001 9 (69.2) 4 (80.0) 1.00 25 (53.2) 6 (75.0) 0.72
BSA, m2 1.6 ± 0.2 1.7 ± 0.2 < 0.001 1.7 ± 0.2 1.6 ± 0.2 0.12 1.6 ± 0.2 1.7 ± 0.1 0.34
Hypertension 208 (52.7) 23 (53.5) 1.00 7 (53.8) 5 (100.0) 0.11 26 (55.3) 4 (50.0) 1.00
Atrial fibrillation 59 (14.9) 6 (14.0) 1.00 3 (23.1) 1 (20.0) 1.00 2 (4.3) 2 (25.0) 0.10
PCI or CABG 88 (22.3) 6 (14.0) 0.29 6 (46.2) 3 (60.0) 1.00 14 (25.5) 0 (0.0) 0.10
Rheumatic valvular disease 37 (9.4) 1 (2.3) 0.12 2 (15.4) 0 (0.0) 1.00 6 (12.8) 2 (25.0) 0.33
B-type natriuretic peptide, pg/mL 106.0 (49.0 –282.5) 51.0 (31.0 –190.5) 0.05 1118.0 (304.8–3066.0) 738.5 (239.3–3227.5) 0.80 59.0 (32.5–180.5) 200.5 (59.0–305.3) 0.38
lnBNP 4.7 (3.9–5.6) 3.9 (3.4–5.2) 0.05 7.0 (5.7–8.0) 6.6 (5.0–7.9) 0.60 4.1 (3.5–5.2) 5.2 (4.1–5.7) 0.12
Blood urea nitrogen, mg/dL 17.7 ± 7.2 20.4 ± 10.2 0.10 25.2 ± 16.7 18.6 ± 4.7 0.22 18.8 ± 8.5 18.0 ± 4.7 0.81
Creatinine, mg/dL 0.9 ± 0.6 1.4 ± 1.9 0.09 2.1 ± 2.3 1.9 ± 1.3 0.76 1.0 ± 0.4 0.9 ± 0.1 0.46
Echocardiography
LVEF, % 60.3 ± 10.1 60.8 ± 8.9 0.72 36.9 ± 11.2 33.8 ± 8.0 0.59 62.8 ± 5.4 61.5 ± 4.6 0.53
Peak velocity, m/s 5.2 ± 0.7 4.9 ± 0.6 0.006 3.6 ± 0.4 3.4 ± 0.7 0.37 3.5 ± 0.5 3.6 ± 0.6 0.67
Peak PG, mmHg 109.8 ± 31.0 96.9 ± 22.4 0.001 53.5 ± 11.7 48.0 ± 17.0 0.44 49.5 ± 16.0 53.4 ± 16.9 0.53
Mean PG, mmHg 67.3 ± 19.7 58.5 ± 14.7 0.001 30.8 ± 6.8 27.2 ± 10.6 0.41 27.7 ± 9.4 29.8 ± 10.2 0.59
LVMI, g/m2 135.4 ± 35.8 134.8 ± 36.5 0.91 151.5 ± 33.5 144.7 ± 26.3 0.69 121.5 ± 32.7 144.6 ± 50.6 0.10
AV VTI, cm 127.2 ± 25.7 101.0 ± 16.5 < 0.001 101.3 ± 34.2 78.2 ± 26.9 0.20 114.2 ± 28.2 98.9 ± 21.3 0.15
LVOT VTI, cm 21.3 ± 4.1 22.6 ± 3.6 0.04 16.0 ± 4.8 16.2 ± 3.8 0.92 21.4 ± 3.6 19.7 ± 3.7 0.24
LVOT diameter, mm 21.0 ± 1.5 21.4 ± 1.5 0.10 22.1 ± 2.2 21.2 ± 0.2 0.22 21.0 ± 1.4 22.2 ± 2.2 0.18
LVOT diameter/BSA 12.9 ± 1.3 12.3 ± 1.0 < 0.001 12.9 ± 1.6 13.6 ± 1.4 0.40 13.0 ± 1.4 13.2 ± 1.2 0.75
AVAecho, mm2 59.0 ± 13.6 80.4 ± 8.8 < 0.001 61.1 ± 12.8 81.9 ± 9.1 0.005 68.2 ± 13.6 77.3 ± 12.7 0.08
ESVI 27.7 ± 16.9 28.0 ± 16.4 0.92 63.0 ± 30.0 64.4 ± 20.0 0.92 23.4 ± 10.6 30.7 ± 14.5 0.10
EDVI 66.6 ± 23.4 68.7 ± 26.7 0.57 96.4 ± 32.6 95.9 ± 21.3 0.98 62.0 ± 22.6 78.4 ± 31.5 0.08
SAC, mL/m2/mmHg 0.8 ± 0.3 0.8 ± 0.3 0.11 0.7 ± 0.3 0.6 ± 0.1 0.52 0.7 ± 0.3 1.0 ± 0.5 0.21
Zva, mmHg/mL/m2 5.4 ± 1.6 5.2 ± 1.7 0.51 4.7 ± 1.7 5.8 ± 2.2 0.82 4.5 ± 1.4 3.8 ± 1.5 0.21
CT findings
Valve morphology 0.04 0.28 0.14
 Tricuspid 177 (44.8) 27 (62.8) 9 (69.2) 5 (100.0) 26 (55.3) 2 (25.0)
 Bicuspid 218 (55.2) 16 (37.2) 4 (30.8) 0 (0.0) 21 (44.7) 6 (75.0)
 AVC, Agatston unit 2834.2 (1605.2–4178.4) 2426.7 (1616.1–3808.9) 0.57 3912.2 (2247.0–4496.1) 1360.1 (960.1–2108.6) 0.002 2002.4 (1192.2–2841.6) 2584.3 (1306.5–5172.0) 0.12
 AVACT 80.9 ± 18.8 136.6 ± 29.6 < 0.001 92.4 ± 15.5 122.7 ± 25.2 0.007 90.2 ± 22.4 117.7 ± 27.9 0.003
 AVAplani, mm2 85.2 ± 22.1 105.0 ± 26.1 < 0.001 88.2 ± 20.0 129.9 ± 5.4 < 0.001 90.1 ± 21.2 140.9 ± 13.8 < 0.001
 LVOT area 346.8 ± 50.0 359.6 ± 51.3 0.11 587.5 ± 129.7 572.3 ± 79.9 0.81 468.9 ± 94.5 581.3 ± 94.9 0.003
Aortic annulus
 Maximum diameter, mm 27.1 ± 3.0 30.6 ± 3.2 < 0.001 30.6 ± 3.9 30.0 ± 2.1 0.77 27.1 ± 2.6 29.0 ± 3.6 0.05
 Circularity, % 80.0 ± 1.0 80.0 ± 1.0 0.22 77.6 ± 7.5 76.9 ± 4.4 0.84 82.0 ± 5.7 83.8 ± 7.6 0.18
 Mean diameter, mm 24.6 ± 2.5 27.5 ± 2.6 < 0.001 27.1 ± 2.9 26.5 ± 1.4 0.70 24.7 ± 2.3 27.0 ± 3.0 0.01
 Perimeter, mm 78.7 ± 8.0 87.3 ± 8.6 < 0.001 86.0 ± 8.9 83.8 ± 3.7 0.46 78.7 ± 7.4 87.3 ± 10.0 0.01
 Area, mm2 471.4 ± 95.0 576.8 ± 119.4 < 0.001 563.3 ± 116.1 532.8 ± 45.9 0.44 475.2 ± 91.3 572.9 ± 113.2 0.009
Sinus of Valsalva, mm 36.2 ± 4.5 39.4 ± 3.8 < 0.001 39.3 ± 4.9 36.1 ± 3.4 0.20 35.9 ± 4.6 42.0 ± 4.2 0.001
Sinotubular junction, mm 30.7 ± 4.6 32.8 ± 4.4 0.004 32.1 ± 3.5 30.7 ± 2.8 0.44 30.6 ± 5.1 36.7 ± 7.7 0.006
Ascending aorta, mm 40.7 ± 6.3 41.0 ± 5.8 0.74 39.5 ± 4.4 35.5 ± 4.2 0.10 39.6 ± 7.1 45.1 ± 9.8 0.06
Normalized to BSA
AVACT 51.8 ± 13.0 59.7 ± 15.7 < 0.001 53.9 ± 9.4 78.3 ± 16.1 0.001 55.9 ± 14.3 70.3 ± 17.9 0.01
AVAplani, mm2 52.4 ± 13.5 60.9 ± 16.4 < 0.001 51.5 ± 12.3 82.7 ± 6.0 < 0.001 55.7 ± 12.7 84.1 ± 10.4 < 0.001
LVOT area, mm2 294.1 ± 61.4 322.3 ± 62.4 0.005 341.2 ± 69.4 365.5 ± 54.6 0.50 289.3 ± 55.3 345.5 ± 54.4 0.01
Aortic annulus
 Maximal dimeter, mm 16.7 ± 1.9 17.7 ± 2.0 0.002 17.9 ± 2.8 19.2 ± 2.0 0.35 16.8 ± 1.7 17.4 ± 1.6 0.37
 Mean diameter, mm 15.2 ± 1.6 15.9 ± 1.6 0.006 15.8 ± 2.0 17.0 ± 1.7 0.27 15.3 ± 1.6 16.1 ± 1.6 0.20
 Perimeter, mm 48.5 ± 5.2 50.4 ± 5.1 0.02 50.2 ± 6.0 53.6 ± 5.0 0.28 48.7 ± 4.9 52.0 ± 6.8 0.10
 Area, mm2 289.3 ± 53.4 331.3 ± 60.0 < 0.001 327.6 ± 65.3 339.7 ± 26.4 0.70 292.7 ± 50.4 341.4 ± 71.4 0.02
Sinus of Valsalva 36.2 ± 4.5 39.4 ± 3.8 < 0.001 22.9 ± 3.0 23.0 ± 2.4 0.95 22.1 ± 2.6 25.1 ± 3.5 0.007
Sinotubular junction diameter 30.7 ± 4.6 32.8 ± 4.4 0.004 18.7 ± 1.9 19.6 ± 2.5 0.40 18.9 ± 2.5 21.9 ± 5.3 0.01
Ascending aorta tubular portion 40.7 ± 6.3 41.0 ± 5.8 0.74 23.1 ± 3.0 22.6 ± 2.9 0.78 24.5 ± 4.3 26.9 ± 5.7 0.18
Surgical valve size, mm 21.9 ± 2.1 23.5 ± 1.8 < 0.001 23.2 ± 2.3 22.6 ± 1.7 0.63 22.1 ± 2.1 23.3 ± 1.7 0.14
MACCE (cardiovascular death) 30 (7.6) 4 (9.3) 0.92 2 (15.4) 3 (60.0) 0.10 4 (8.5) 0 (0.0) 1.00
All-cause mortality 52 (13.2) 5 (11.6) 0.96 4 (30.8) 2 (40.0) 1.00 7 (14.9) 1 (12.5) 1.00

AS, aortic stenosis; AVA, aortic valve area; AVACT, AVA measured on CT; AVC, aortic valve calcium score; BSA, body surface area; CABG, coronary artery bypass graft; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; LF-LG, low-flow and low-gradient; lnBNP, log-transformed B-type natriuretic peptide; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; LVOT, left ventricular outflow tract; MACCE, major adverse cardiac and cerebrovascular event; PCI, percutaneous coronary artery intervention; VTI, velocity time integral.